Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Analytical Biochemistry|January 10, 2002
Engineering a V(2) vasopressin receptor agonist- and regulator of G-protein-signaling-sensitive G proteinGui-Jie Feng, Antonella Cavalli, Graeme Milligan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2007
Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapyCynthia Aristei, Roberto Tarducci, Isabella Palumbo, et al.
Journal of Neurochemistry|May 20, 2003
Concerted stimulation and deactivation of pertussis toxin-sensitive G proteins by chimeric G protein-coupled receptor-regulator of G protein signaling 4 fusion proteins: analysis of the contribution of palmitoylated cysteine residues to the GAP activity of RGS4Daljit S Bahia, Nana Sartania, Richard J Ward, et al.
The Journal of Investigative Dermatology|July 31, 2009
TSH receptor and thyroid-specific gene expression in human skinFrancesca Cianfarani, Enke Baldini, Antonella Cavalli, et al.
The Journal of Clinical Endocrinology and Metabolism|June 16, 2005
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonismDomenico Cozzolino, Ferdinando C Sasso, Donato Cataldo, et al.
Brachytherapy|November 12, 2018
Individualized 3D-printed templates for high-dose-rate interstitial multicathether brachytherapy in patients with breast cancerCynthia Aristei, Valentina Lancellotta, Marco Piergentini, et al.
Molecular Microbiology|July 17, 2004
The bromodomain-containing protein Bdf1p acts as a phenotypic and transcriptional multicopy suppressor of YAF9 deletion in yeastMichele M Bianchi, Giovanna Costanzo, Anna Chelstowska, et al.
Journal of Cardiovascular Pharmacology|October 7, 2020
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World ExperienceVincenzo Russo, Giuseppe Cardillo, Giuseppe Vito Viggiano, et al.
Viruses|September 28, 2021
The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort StudyPierpaolo Di Micco, Antonella Tufano, Giuseppe Cardillo, et al.
Frontiers in Medicine|December 17, 2020
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational StudyVincenzo Russo, Giuseppe Cardillo, Giuseppe Vito Viggiano, et al.
Pageof 2